Obicetrapib potassium

Overview

Obicetrapib (TA-8995; DEZ-001) potassium is an orally active cholesteryl ester transfer protein ( CETP ) inhibitor. Obicetrapib potassium potently reduces atherogenic lipoproteins (such as LDL-C, ApoB , Lp (a)) and increases HDL-C. Obicetrapib potassium can be used for the research of dyslipidemia and atherosclerotic cardiovascular disease (ASCVD).

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Lipid Metabolism | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Apolipoprotein | Products > Signaling Pathways > LDLR | Products > Signaling Pathways > LPL Receptor | Products > Signaling Pathways > CETP

Product Information

• Catalog No.: HY-18778B
• CAS No.: 866399-90-8
• Molecular Formula: C32H30F9KN4O5
• Molecular Weight: 760.69
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source